Cargando…
Targeted Therapy for MAPK Alterations in Pediatric Gliomas
Although the mitogen-activated protein kinase (MAPK) pathway helps promote normal cell development, the pathway is known to contribute to the initiation and growth of many types of cancers. Tumorigenesis can result from mutations in a number of the pathway’s key proteins, including but not limited t...
Autores principales: | Truong, AY, Nicolaides, TP |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627711/ https://www.ncbi.nlm.nih.gov/pubmed/26525348 http://dx.doi.org/10.4172/2168-975X.S2-005 |
Ejemplares similares
-
Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAF(V600E) targeted inhibition in a novel syngeneic murine glioma model
por: Grossauer, Stefan, et al.
Publicado: (2016) -
Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma
por: Koschmann, Carl, et al.
Publicado: (2016) -
MODL-17. SHP2 INHIBITORS SHOW ACTIVITY AGAINST NF1-DEFICIENT GLIOMAS AND ENHANCE MAPK PATHWAY INHIBITION IN BRAF-V600E MUTANT GLIOMAS
por: Muldoon, Daniel, et al.
Publicado: (2020) -
EGFR blockade prevents glioma escape from BRAF(V600E) targeted therapy
por: Yao, Tsun-Wen, et al.
Publicado: (2015) -
DIPG-18. AI HUNTING FOR NEW DRUGS IN PEDIATRIC GLIOMA
por: Hashizume, Rintaro, et al.
Publicado: (2023)